Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma
Crossref DOI link: https://doi.org/10.1007/s00005-016-0442-6
Published Online: 2017-01-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Butrym, Aleksandra
Ĺacina, Piotr
Rybka, Justyna
Chaszczewska-Markowska, Monika
Mazur, Grzegorz
Bogunia-Kubik, Katarzyna
Funding for this research was provided by:
Wroclaw Medical University (ST-370)
License valid from 2016-12-01